*Warnings to General Public:- “The below classified information (Intellectual Property) is totally & fully protected & secured under the Law of Malaysia, and is subject to release to public viewing only & strictly under purview of personal information & copyright of the owner, who has absolute total legal rights & privileges under the Law of Malaysia. No one else other than The Owner/ The Company has any legal (lawfully given) rights to transfer, copy, snapshot or make photographic effort or share in any form the legally classified information below. Anyone who falsely attempts to use or claims or comments or takeover or interrupt or make or suggest or transform or transfer or link or share the below information in the form of any types of emails / SMS / Whatsapp / Wechat / Line / all social media platforms and etc without STRICT PERMISSION of the Owner/ The Company is strongly advised NOT TO DO SO as it is legally prohibited. Anyone or any entities who illegally has access to the above classified documents / in-depth information and illegally annouce, inform, publicize , distribute, share or disseminate the above information in any formats, without prior permission & recognition by THE OWNER / THE COMPANY and RELEVANT HEALTH AUTHORITIES OF MALAYSIA shall be deemed as CRIMINAL. The Criminal/s (who purposefully & willfully violate/s the above LAW or LEGAL RIGHTS OF THE OWNER/ THE COMPANY ) will be faced with jail terms, strong penalties and fines if found guilty under the JURISDICTION of MALAYSIA.”
PROF* DR HARRY YEO KAR KIAT
Head Of Medical Unit Of ZÉLL-V
* Title of (Visiting) Professor in Radiation Sciences while previously serving as part of a technical committee under a key Malaysian governtment national agency
MEDICAL SPECIALTIES / INTERESTS
Clinical Medicine, Cellular Biology & Radiation Sciences, Clinical Research, Preventive/Cancer/Palliative Medicine
HONOURS/MEMBERSHIPS
MBBS (Sydney), C.UGClinRes (Oxford), Cand DPhil (Oxford), Harvard Medical School (USA), SpDipRadBio (Eur), SpDipRTPhys (Eur),
ESMO Academy (Oxford), SpT RadOnc (CF level, Australia), Adv SpT Pall Med (CF level, Australia), ESMO, ESTRO, ASCO (USA), TROG (AUST), NYAS (USA), MOS, MASP, MMA
BIOGRAPHY
Prof* Dr Harry Yeo Kar Kiat's Personal Biography
He graduated from Sydney University Medical School , MBBS (Sydney) in 2001;
He also obtained an undergraduate research certificate from Oxford University Medical School { C.UGClinRes (Oxford) } in the late 2000s while doing his Clinical Neurology research at the Radcliffe Infirmary of Oxford University;
He successfully completed one year compulsory housemanship at both venues : Sydney's Concord Repatriation General Hospital of Australia and the General Hospital of Singapore, in 2001/02.
Officially became a fully qualified & registered medical doctor, both in Singapore & Australia in 2002;
Served as specialty registrar in Radiation Oncology @ Australian university hospitals from 2004 to 2006;
Successfully completed and awarded two specialist-level Diplomas in Radiation Oncology Basic Sciences { SpDip RadBio (Eur) & SpDip RTPhys (Eur) } organised by ESTRO based @ Europe (Belgium & Switzerland) in the late 2004s;
Appointed as Clinical Lecturer (Junior Level) in Radiation Oncology at an Australian University Medical School in 2005-2006;
Dr Yeo has become an Affiliated Member of the exclusive Australian and New Zealand cancer research Group since 2005;
Served as Advanced Trainee in Palliative Medicine (Clinical Fellow level) at major teaching university hospitals in Australia in 2007;
In 2005-2008, Dr Yeo became Member of 3 major medical specialty training faculties in Australia;
Unconditionally and legally registered as fully qualified doctor and voting member with Malaysian medical regulatory bodies since 2008.
Upon invitation and approval by relevant health authorities in Malaysia, he returned and served as Consultative Medical Officer (CMO) for Clinical Oncology Services at a key Malaysian Tertiary-Level governmental hospital in KL, Malaysia from 2008 to 2011;
During the same period of time, he was also appointed as Consultant Clinical Oncologist for Clinical Research Project: National Cancer Patient Registry (NCPR) , Clinical Research Centre (CRC), at a key Malaysian tertiary-level governmental hospital in KL, Malaysia from 2008 to 2011;
In 2009/10, he was selected as World Top 5% Doctorate Candidate in Radiobiology (Radiation Oncology) at the world-renowned Gray's Institute, University of Oxford { Cand DPhil RadOnc (Oxford) } after highly competitive world-wide interview rounds -- deferred till suitable time due to multiple factors;
He was appointed as an expert in capacity of (Visiting) Professor* of Radiation Sciences and also a Malaysian medical professional authority's representative for Technical Committee at a key Malaysian national agency (2012-2014);
He was also offered on part-time basis as Candidate for Professional Doctorate in Public Health at Monash University (Malaysia Campus), { C DrGaPH (Monash) } from 2014 to 2022;
Successfully attended ESMO Academy (Pre-ESMO Fellowship Preparation Course) at Oxford, UK and obtained the highly regarded EACCME(Europe)/AMA (USA)/RCPSC (Canada)-endorsed medical specialist certificate {ESMO Academy } in 2015;
In 2016-17, Dr Yeo was a medical consultant cum clinical researcher heavily involved in Japanese-originated Clinical Cancer Immunotherapy Case Trial (Public-Private Partnership) at a local KL medical centre ; [Cancer Immunotherapy is widely regarded now as 4th Pillar of Cancer Treatments after Surgery, Radiotherapy and Drug/Chemotherapy, after two prominent scientists in cancer immunotherapy (from Japan & USA) won the 2018 Nobel Medicine Prize this year due to their ground breaking work in
anti-PD-1 & anti-CTLA4 immunotherapy ]
Due to his outstanding leadership qualities and contributions in medical / clinical services, Dr Yeo is the latest recipient of Harvard University Medical School (USA) Scholarship with official admission into the highly selective Harvard Medical
School-run Healthcare Leadership Programme in 2018/19;
Now He is a Full International Member for ESTRO, ESMO, ASCO and TROG (AUST),
NYAS (USA) since 2011.
*The above info was appropriately registered, recorded and classified by the relevant Health Authorities of Malaysia under the appropriate rules and regulations of the Law in Malaysia.* Anyone or any entities who illegally has access to the above classified documents / in-depth information and illegally annouce, inform, publicize , distribute, share or disseminate the above information in any formats, without prior permission & recognition by THE OWNER / THE COMPANY and RELEVANT HEALTH AUTHORITIES OF MALAYSIA shall be deemed as CRIMINAL. The Criminal/s (who purposefully & willfully violate/s the above LAW or LEGAL RIGHTS OF THE OWNER/ THE COMPANY ) will be faced with jail terms, strong penalties and fines if found guilty under the JURISDICTION of MALAYSIA."